INTRODUCTION
============

To reach their functional states, newly synthesized polypeptides need to fold into their specific three-dimensional structures. Many proteins use the help of chaperones for surveillance of these folding reactions, for example, by preventing or reversing nonproductive folding intermediates ([@B11]; [@B34]). Members of the Hsp70 family play a pivotal role in protein folding and are present in most cellular compartments, including the cytosol, the mitochondrial matrix, and the endoplasmic reticulum ([@B40]). However, Hsp70 isoforms and other ATP-hydrolyzing chaperones appear to be absent from the intermembrane space (IMS) of mitochondria, and it is not known how IMS proteins are folded ([@B35], [@B36]; [@B79]; [@B38]).

About half of the ∼60 different proteins identified in the IMS of yeast mitochondria ([@B79]) contain structural disulfide bonds that are introduced during their folding process. Oxidative folding of these proteins coincides with their import across the outer membrane and is mediated by the essential oxidoreductase Mia40 ([@B17]; [@B59]; [@B56]; [@B44]). The conserved critical domain of Mia40 forms a helix-loop-helix fold in which the two antiparallel α-helices are connected by two parallel disulfide bonds ([@B5]; [@B41]). These helices form on one side a hydrophobic dish-like cavity that is crucial for the binding and translocation of its substrates across the outer membrane. N-terminally adjacent to this binding region is a flexible arm that contains a cysteine-proline-cysteine (CPC) sequence mediating disulfide bond formation in bound substrates. Reoxidation of Mia40 is catalyzed by the sulfhydryl oxidase Erv1 ([@B50]; [@B2]; [@B56]; [@B74]). This conserved flavoprotein generates disulfides de novo and transfers electrons via cytochrome *c* and cytochrome *c* oxidase to molecular oxygen, giving rise to the production of water ([@B24]; [@B9]; [@B22]; [@B26]).

Most Mia40 substrates belong to two groups of proteins that are referred to as "twin Cx~3~C" and "twin Cx~9~C" proteins. The twin Cx~3~C proteins are also called small Tim proteins owing to their essential role in protein import ([@B45]; [@B69]; [@B16]). They bind to inner membrane carriers during their import into mitochondria and usher them from the translocase of the outer membrane of mitochondria pore in the outer membrane to their insertion site in the inner membrane. These small Tim proteins form stable hexameric complexes and exhibit chaperone activity in in vitro folding assays ([@B77]; [@B81]). However, in mitochondria, they presumably interact with a specific subset of precursors of hydrophobic membrane proteins and maintain them in a translocation-competent state rather than promote their folding.

The twin Cx~9~C proteins form a relatively large protein family (14 members in yeast, 29 in mammals), but the function of most of these factors is unclear ([@B29]; [@B52]; [@B15]). Except for Mia40, all twin Cx~9~C proteins are small (7--14 kDa) and consist almost exclusively of the helix-loop-helix region. Mdm35 was found to serve as dynamic binding partner for the lipid transport protein Ups1 ([@B63]; [@B72]). Dynamic interactions of Ups1 and Mdm35 were proposed to drive the regulated transfer of phosphatidic acid from the outer to the inner membrane ([@B19]).

Here we screened for interaction partners for Cox19, a conserved twin Cx~9~C protein that is ubiquitously found in mitochondria of animals, fungi, and plants (Supplemental Figure S1). Cox19 was initially identified as an assembly factor for cytochrome *c* oxidase, but its specific function in this process remained unclear ([@B60]; [@B65]). Owing to the observation that recombinant Cox19 can bind to copper in a 1:1 stoichiometry, it was suggested that Cox19 might serve as copper-binding protein. However, the four cysteine residues of Cox19 that are critical for metal binding in vitro are oxidized in vivo ([@B65]; [@B8]; [@B27]). Therefore a direct copper-binding activity of Cox19 in mitochondria is questionable (compare structure in [Figure 1A](#F1){ref-type="fig"}).

![SILAC-based proteomic analysis identifies Cox11 as an interaction partner of Cox19. (A) The Cox19 structure was modeled on the basis of the yeast Mia40 structure (Protein Data Bank ID 2K3J; [@B5]) using the I-TASSER algorithm ([@B83]) and was visualized with Chimera ([@B62]). Cysteine residues are shown in yellow. (B) Addition of the hexahistidine tag to Cox19 does not compromise its activity. The indicated strains were grown to log phase in galactose medium. Tenfold serial dilutions were dropped onto YPD (glucose) or YPG (glycerol) plates and incubated for 2 or 4 d, respectively. (C) Western blotting of mitochondria (100 μg) isolated from the indicated strains. (D) A 10-mg amount of mitochondria was lysed and either directly applied to SDS--PAGE (total) or used for affinity purification on Ni-NTA Sepharose. The proteins contained in washing steps and the elution after addition of 400 mM imidazole were precipitated by TCA and detected by Western blotting with Cox19-specific antibodies. The total and not-bound (NB) samples correspond to 7.5% of the material used for the other samples. (E) Principle of SILAC labeling to compare protein levels from Ni-NTA eluates of extracts from Cox19-His~6~ and wild-type mitochondria. (F, G) Enrichment factors from two independent experiments. (H) Model of the Cox19--Cox11 interaction.](2385fig1){#F1}

Although mutants in many of the twin Cx~9~C proteins lead to distinct phenotypes such as the absence of respiratory activity, the analysis of their biochemical function turned out to be difficult. In part, this might be due to the fact that most of these proteins are present only at very low amounts, so that they easily escape detection by proteomic analyses ([@B79]; [@B38]). We therefore combined affinity purification mass spectrometry with the stable isotope labeling by amino acids in cell culture (SILAC) strategy ([@B61]) to screen for proteins that associate with Cox19 in yeast mitochondria. In this way, Cox11 was identified as a prominent interaction partner of Cox19. Of interest, both proteins form a nonpersistent redox-dependent complex in the IMS. Cox11 binding to Cox19 depends on a hydrophobic region on Cox19 formed by the two disulfide-linked helices. This interaction is reminiscent of the binding of IMS proteins by Mia40, which was shown to serve, in addition to its role as oxidoreductase, as a chaperone for IMS proteins ([@B82]). On the basis of our observations, we propose that twin Cx~9~C proteins serve as folding modulators in the IMS, which induce conformational changes of their client proteins. These folding modulators either interact with soluble IMS proteins, as in the case of the Mdm35-Ups1 interaction, or with inner membrane proteins, which expose larger structural domains into the IMS such as in the case of the Cox19--Cox11 interaction shown in this study.

RESULTS
=======

SILAC-based proteomics identifies Cox11 as an interaction partner of Cox19
--------------------------------------------------------------------------

To identify potential interaction partners of the twin Cx~9~C protein Cox19 in the IMS, we generated a yeast strain in which Cox19 carries a C-terminal hexahistidine tag (Cox19-His~6~) by a chromosomal integration strategy to keep its expression under control of its endogenous promoter ([@B47]). The resulting Cox19-His~6~ strain showed robust growth even on nonfermentable carbon sources, whereas a *COX19*-deletion strain (*Δcox19*) was unable to respire ([Figure 1B](#F1){ref-type="fig"}). Moreover, the levels of the tagged Cox19 protein were indistinguishable from those of wild-type (wt) Cox19 ([Figure 1C](#F1){ref-type="fig"}). The Cox19-His~6~ protein could be efficiently purified from isolated mitochondria on a nickel-nitriloacetic acid (Ni-NTA) resin, whereas the nontagged Cox19 protein was not recovered ([Figure 1D](#F1){ref-type="fig"}).

We decided to use a highly sensitive, quantitative proteomics approach for the detection of Cox19 interactors to reduce the risk of false-positive hits. SILAC appeared to be a perfect method in this case ([@B61]), since protocols were established for yeast cultures that were successfully used to identify interaction partners of mitochondrial proteins ([@B23]; [@B33]; [@B78]; [@B30]). We grew yeast cells in minimal media containing either light (Cox19-His~6~) or heavy (^13^C~6~ ^15^N~4~-L-arginine, ^13^C~6~ ^15^N~2~-L-lysine; wt) amino acids ([Figure 1E](#F1){ref-type="fig"}). In two independent experiments, we isolated mitochondria from these strains, which were lysed and used for affinity chromatography on Ni-NTA resin. The eluates were mixed in a 1:1 ratio, tryptically digested, and analyzed by nano liquid chromatography--electrospray ionization tandem mass spectrometry on an Orbitrap instrument. Peptide identification and quantification was performed with the MaxQuant software package ([@B20]). Among the \>300 proteins identified in the eluates (Supplemental Table S1), only two were consistently enriched in both experiments ([Figure 1F](#F1){ref-type="fig"}): our bait protein Cox19, which was enriched by factors of 17.0 and 14.4 over background, and Cox11, which was enriched by factors of 14.7 and 12.4. None of the other proteins identified was enriched with Cox19-His~6~ in both of the purifications.

Cox11 is a conserved assembly factor for cytochrome *c* oxidase that is tethered to the inner membrane by an N-terminal membrane anchor ([Figure 1H](#F1){ref-type="fig"}); it exposes a domain of 193 residues into the IMS, which is critical for copper insertion into subunit 1 of cytochrome *c* oxidase (Cox1; [@B75]; [@B13]; [@B4]; [@B37]).

Cox19 and Cox11 can be copurified from mitochondrial extracts
-------------------------------------------------------------

To verify a potential interaction of Cox11 and Cox19, we purified Cox19 from Triton X-100 extracts of Cox19-His~6~ mitochondria by affinity chromatography ([Figure 2A](#F2){ref-type="fig"}). Cox11 was identified in the eluate fractions together with Cox19-His~6~, whereas neither Cox11 nor Cox19 was found upon control purification with wild-type mitochondrial extracts. This confirms the results of the SILAC data and shows that Cox11 is associated with Cox19-His~6~.

![The Cox19--Cox11 interaction is confirmed by reciprocal copurification experiments from mitochondrial extracts. (A) Affinity purification of extracts of mitochondria purified from Cox19-His~6~ and wild-type cells. Total and NB samples correspond to 1% of the material used for the other samples. (B) Mutants carrying a C-terminal hexahistidine tag on Cox11 are still able to grow on nonfermentable carbon source. (C) Cox19 can be copurified with Cox11-His~6~ on Ni-NTA material. (D) Mutants lacking Cox19 or Cox11 show increased sensitivity to hydrogen peroxide. Cells were grown to log phase in glucose medium and diluted to an OD of 0.5. After 2 h of incubation at 30°C with or without 6 mM hydrogen peroxide, cells were dropped onto YPD plates.](2385fig2){#F2}

Next we asked whether the Cox11--Cox19 interaction is also observed upon purification of Cox11. To this end, we generated a Cox11 variant with a C-terminal hexahistidine tag (Cox11-His~6~). The tagged Cox11 is functional, as indicated by the ability of the Cox11-His~6~ yeast strain to grow on a non­fermentable carbon sources, whereas a *COX11*-deletion strain (*Δcox11*), similar to the *COX19*-deletion strain, was unable to respire ([Figure 2B](#F2){ref-type="fig"}). Cox11-His~6~ was efficiently purified on the Ni-NTA resin from Cox11-His~6~ mitochondria, and a large proportion of Cox19 was copurified ([Figure 2C](#F2){ref-type="fig"}). From this, we conclude that Cox11 physically interacts with Cox19 in the IMS of mitochondria.

The identification of Cox11 as a potential Cox19 interactor was highly interesting. Both proteins are essential for cytochrome *c* oxidase biogenesis, but an interaction of Cox11 and Cox19 had not previously been observed. We therefore tested how similar the phenotypes are that result from the deletion of Cox11 or Cox19. The absence of Cox11 leads to the accumulation of an assembly intermediate of cytochrome *c* oxidase that renders yeast cells highly sensitive toward exposure to hydrogen peroxide ([@B7]; [@B43], [@B42]; [@B76]; [@B10]). We therefore tested whether the *Δcox19* mutant shows comparable hydrogen peroxide sensitivity and indeed observed that the absence of Cox19 also renders cells particularly susceptible to oxidative damage, which was not found for *Δoxa1* mutants, which also lack cytochrome *c* oxidase activity ([Figure 2D](#F2){ref-type="fig"}). This comparable phenotype is consistent with a role of Cox11 and Cox19 in the same step of cytochrome *c* oxidase biogenesis.

Size exclusion chromatography indicates that Cox11 and Cox19 do not form a stable complex in the IMS
----------------------------------------------------------------------------------------------------

To analyze further the association of Cox11 and Cox19, we lysed isolated wild-type mitochondria with Triton X-100 and separated the protein complexes by size exclusion chromatography on a HiLoad 16/60 Superdex 200 column ([Figure 3, A and B](#F3){ref-type="fig"}). Cox11 migrated with an apparent mass of ∼170 kDa, whereas Cox19 eluted very late from the column in fractions with a peak of an apparent mass of ∼20 kDa. We did not observe Cox11 in the Cox19 fraction or Cox19 in the Cox11 fraction, suggesting that the interaction of Cox11 and Cox19 observed by Ni-NTA purification is rather labile and/or transient. In agreement with earlier studies, neither protein migrated with Cox2, nor was their migration altered in the absence of cytochrome *c* oxidase (*Δcox6*), indicating that they are not stable constituents of cytochrome *c* oxidase, as already shown by others ([@B60]; [@B42]). The amounts of assembled cytochrome *c* oxidase were severely reduced in both *Δcox19* and *Δcox11* mitochondria, as indicated by low amounts of Cox2 the high--molecular weight elution fractions of the gel filtration compared with wild-type mitochondria ([Figure 3A](#F3){ref-type="fig"}). These data, together with the inability of the deletion mutants to grow on nonfermentable carbon sources, confirm that both Cox11 and Cox19 play crucial roles in the biogenesis of cytochrome *c* oxidase.

![Cox11 and Cox19 are not part of a common stable protein complex. (A) Mitochondria (3 mg) were isolated from the strains indicated and lysed in 500 μl of 25 mM Tris, pH 7.4, 250 mM NaCl, 1% Triton-X 100, and 2 mM PMSF. After a purifying centrifugation at 25,000 × *g* for 30 min at 4°C, the clarified extract was applied to size exclusion chromatography on a HiLoad 16/60 Superdex 200 column. Proteins were TCA precipitated from the resulting fractions and analyzed by Western blotting. Distribution of cytochrome *c* oxidase (COX, green), Cox11 (blue), and Cox19 (red) in wild-type extracts. (B) Quantification of the experiment in A.](2385fig3){#F3}

The apparent molecular mass of the 170-kDa Cox11 complex was not changed in mitochondria from a *Δcox19* strain, indicating that Cox19 is not essential for its formation or maintenance ([Figure 3, A and B](#F3){ref-type="fig"}). However, it is of interest that no Cox19 was detectable in *Δcox11* mutants, suggesting that Cox11 is required for the stable accumulation of Cox19 in the IMS of mitochondria.

Deletion of Cox11 leads to reduced levels of Cox19 in mitochondria
------------------------------------------------------------------

To better assess the relevance of Cox11 for the accumulation of Cox19 in mitochondria, we compared the steady-state protein levels of Cox11 and Cox19 in *Δcox19* and *Δcox11* mutant mitochondria ([Figure 4A](#F4){ref-type="fig"}). We found that the levels of Cox11 are not considerably influenced by the deletion of Cox19. Moreover, overexpression of Cox19 also did not affect the amounts of the Cox11 protein in mitochondria. Hence Cox19 appears not to be critical for the biogenesis of Cox11. However, on the contrary, Cox19 was again almost undetectable in *Δcox11* mitochondria. A comparable depletion of Cox19 was not observed in other cytochrome *c* oxidase--deficient mitochondria that we tested ([Figure 4B](#F4){ref-type="fig"}).

![Cox11 import does not depend on Cox19. (A, B) Mitochondrial proteins of the indicated strains were analyzed by Western blotting. (C) Radioactive ^35^S-preCox11 was synthesized in reticulocyte lysate and incubated with mitochondria purified from wild-type or *Δcox19* cells. After 5 or 30 min, aliquots were taken and further incubated on ice in the absence or presence of 100 μg/ml proteinase K. Samples were applied to SDS--PAGE and analyzed by autoradiography. Arrowheads indicate the mature ^35^S-Cox11 protein that reached a protease-resistant location, indicating its complete import into the mitochondria. Processing of Cox11 presumably occurs in two steps, in which a higher-migrating intermediate is observed that is not fully imported (asterisk) and hence is not protease resistant. This might correspond to the two alternative N-termini of mature Cox11 that were reported on the basis of a proteomic study ([@B80]). (D) ^35^S-Cox19 was incubated with isolated mitochondria for the times indicated. All samples were treated with proteinase K to remove nonimported material. The samples were analyzed by autoradiography. (E) Mitochondrial proteins of the indicated strains were analyzed by Western blotting. (F) Complementation experiment of the indicated strains. Cells were transformed with plasmids overexpressing Cox11 (top) or Cox19 (bottom), serially diluted, and dropped on glucose and glycerol plates.](2385fig4){#F4}

We next tested whether the interaction of Cox11 and Cox19 is relevant for the import of both components into mitochondria. To this end, we synthesized the precursor form of Cox11 in reticulocyte lysate in the presence of \[^35^S\]methionine and incubated the radioactive protein with isolated yeast mitochondria (^35^S-preCox11; [Figure 4C](#F4){ref-type="fig"}). The in vitro--synthesized Cox11 precursor has an apparent molecular weight of 35 kDa, corresponding well to the calculated mass of 34.5 kDa. On incubation with mitochondria, ^35^S-preCox11 was converted to a faster-migrating form (^35^S-Cox11; [Figure 4C](#F4){ref-type="fig"}), which was partially resistant to externally added proteinase K, indicating its translocation across the outer membrane ([Figure 4C](#F4){ref-type="fig"}, arrowhead). *Δcox19* mitochondria imported Cox11 with the same kinetics as wild-type mitochondria, indicating that Cox19 is not crucial for Cox11 import. Similarly, ^35^S-Cox19 was efficiently imported into *Δcox11* mitochondria, suggesting that also Cox11 is not critical for the import of Cox19 ([Figure 4D](#F4){ref-type="fig"}). It therefore appears unlikely that the reduced levels of Cox19 in *Δcox11* mitochondria is due to reduced import rates of Cox19, but instead is the result of decreased stability of Cox19 in the IMS of *Δcox11* mitochondria. However, Cox19 remained barely detectable even when the iAAA-protease Yme1, which is the major protease of the IMS ([@B51]; [@B66]), was deleted in the *Δcox11* background ([Figure 4E](#F4){ref-type="fig"}).

Next we tested whether overexpression of Cox11 or Cox19 suppresses the defects in *Δcox19* and *Δcox11* cells, respectively ([Figure 4F](#F4){ref-type="fig"}). Overexpression of Cox11 from a multicopy plasmid largely complemented the respiration defect of *Δcox11* cells but did not suppress the defects of *Δcox19* mutants. Similarly, overexpression of Cox19 complemented a *Δcox19* mutant but did not suppress the defects of *Δcox11* strains. Hence we conclude that both factors are critical for biogenesis of cytochrome *c* oxidase, and their relevance is not simply explained by a potential stabilizing effect of one factor for the other.

Cox19 forms a hydrophobic cavity that is essential for its function
-------------------------------------------------------------------

Cox19 is a conserved protein found in mitochondria of fungi, plants, and animals, including humans (Supplemental Figure S1). It is characterized by twin Cx~9~C signatures with conserved tyrosine-leucine (YL) residues at positions 7 and 8 between the cysteine residues (twin Cx~6~YLxC). Modeling of the Cox19 sequence onto the Mia40 structure suggests that these residues are part of a hydrophobic dish-like structure ([Figure 5A](#F5){ref-type="fig"}). This structure is reminiscent of the hydrophobic substrate-binding pocket of Mia40 ([@B5]; [@B41]; [@B67]), but in Cox19, the hydrophobic cavity is surrounded by conserved charged residues ([Figure 5A](#F5){ref-type="fig"}, green and red). In Mia40, mutation of conserved phenylalanine residues in this pocket to glutamate residues had been shown to compromise severely the Mia40--substrate interaction ([@B41]). Following the same strategy, we generated a Cox19^EE^ mutant in which the tyrosine-leucine residues were replaced by glutamate residues. Expression of this variant even from a multicopy plasmid did not rescue the respiration defect of a *Δcox19* mutant, indicating that the Cox19^EE^ mutant is not functional ([Figure 5B](#F5){ref-type="fig"}). Because the conserved tyrosine-leucine residues are part of the two mitochondrial IMS-sorting signal (MISS)/IMS-targeting signal (ITS) signals of Cox19 ([@B67]), we considered it as possible that the Cox19^EE^ mutant might not be properly imported into the IMS. Indeed, the Cox19^EE^ protein was not detectable in isolated mitochondria ([Figure 5C](#F5){ref-type="fig"}).

![Conserved tyrosine-leucine residues are essential for Cox19 activity. (A) Structure of the hydrophobic cavity formed by the twin Cx~6~YLxC motif of Cox19. The structure was modeled as in [Figure 1A](#F1){ref-type="fig"}, but only the helix-loop-helix region is shown. YL dipeptides, dark blue; on rightmost structure, other hydrophobic residues, light blue; negative residues, red; and positive residues, green. (B) Cells from a *Δcox19* strain were transformed with an empty plasmid (control) or plasmids overexpressing Cox19 or Cox19^EE^. Growth was analyzed on SD (glucose) or SG (glycerol) plates. (C) Western blot analysis of mitochondria (100 μg) isolated from Cox19- and Cox19^EE^-expressing cells. (D) Fusion proteins of an IMS-targeting sequence with Cox19 and Cox19^EE^ were overexpressed in *Δcox19* cells. Mitochondria were isolated and analyzed by Western blotting. (E) Cox19 was incubated with 5 mM TCEP, GSH, or GSSG, reisolated by TCA precipitation, and treated with the alkylating agent mm(PEG)~12~. Modification with mm(PEG)~12~ leads to a slower electrophoretic mobility, which is indicative of the presence of reduced thiols. Cox19 was fully oxidized unless treated with the strong reductant TCEP. (F) Mitochondrial proteins of the indicated strains were TCA precipitated and treated with TCEP and/or mm(PEG)~12~. (G) Activities of cytochrome *c* oxidase were analyzed in mitochondria isolated from the indicated strains. (H) Drop dilution experiment of the strains analyzed in D. (I) Cox11 was purified by immunoprecipitation with Cox11-specific antibodies from extracts of mitochondria isolated from the indicated strains. Copurified Cox19 was detected by Western blotting and is indicated by yellow arrows. Note that no Cox11 can be detected in the pull downs with IM-Cox19^EE^.](2385fig5){#F5}

We therefore constructed a variant in which the import of the Cox19^EE^ protein is ensured by fusion to the N-terminal IMS targeting sequence of Mia40, which stably tethers the imported protein to the inner membrane ([Figure 5D](#F5){ref-type="fig"}, inset). A similar strategy relying on a fusion to an inner membrane--spanning domain was successfully used previously to import Cox19 and other twin Cx~9~C proteins into the IMS ([@B54]; [@B65]). The corresponding inner membrane (IM)-Cox19^EE^ fusion protein was well detectable in isolated mitochondria. The slower migration of the IM-Cox19^EE^ fusion compared with that of IM-Cox19 is presumably due to its more acidic nature. The abundance of the IM-Cox19^EE^ protein was comparable to that of the IM-Cox19 fusion ([Figure 5D](#F5){ref-type="fig"}). Cox19 contains two disulfide bonds, which are stable even in the presence of physiological concentrations of glutathione ([@B8]). This can be demonstrated by incubation of Cox19 with the alkylating agent methyl--polyethylene glycol maleimide 12 (mm(PEG)~12~), which adds ∼1.2 kDa to each reduced cysteine residue. As shown in [Figure 5E](#F5){ref-type="fig"}, the four cysteine residues are inaccessible to mm(PEG)~12~ unless Cox19 was pretreated with the thiol-free reducing agent Tris-carboxyethyl phosphine (TCEP). The cysteine residues are also oxidized in IM-Cox19 but reduced in the IM-Cox19^EE^ mutant ([Figure 5F](#F5){ref-type="fig"}). This nicely illustrates that protein oxidation in the IMS depends on the presence of the MISS/ITS signal ([@B57]; [@B67]) and is not just the consequence of "oxidizing conditions" in this compartment.

Measurements of the cytochrome *c* oxidase activity with isolated mitochondria revealed that the expression of the IM-Cox19^EE^ fusion protein was not able to suppress the cytochrome *c* oxidase deficiency of a *Δcox19* mutant to any detectable extent ([Figure 5G](#F5){ref-type="fig"}). Consistent with this, IM-Cox19^EE^ was not able to complement the growth defect of a *Δcox19* mutant ([Figure 5H](#F5){ref-type="fig"}).

Immunoprecipitation from mitochondrial extracts with Cox11-specific antibodies proved that IM-Cox19 still binds to Cox11 ([Figure 5I](#F5){ref-type="fig"}). In contrast, IM-Cox19^EE^ was not recovered with Cox11, indicating that this mutant lost its ability to interact with Cox11. Thus the hydrophobic cavity of Cox19 presumably serves as a binding site for its partner protein Cox11. Comparable Cx~6~YLxC signatures are not present in other members of the twin Cx~9~C family ([@B52]) but are characteristic of Cox19 homologues, for which the tyrosine-leucine dipeptide is invariantly found in the second Cx~9~C helix (Supplemental Figure S1, red).

Cox19 binds to selective regions of the IMS domain of Cox11
-----------------------------------------------------------

After identification of the nonfunctional Cox19^EE^ mutant, we used this variant as a proper control to identify potential binding regions in Cox11 for Cox19. For Mia40, it was shown that the hydrophobic binding cleft interacts with relatively short helical stretches of 9--11 amino acid residues ([@B41]; [@B57]; [@B67]), allowing for the identification of binding motifs by the use of peptide display arrays ([@B82]; [@B53]). We therefore cloned the sequences of Cox19 and the Cox19^EE^ mutant into an *Escherichia coli* expression plasmid and purified recombinant forms of both variants as fusion proteins from bacterial extracts. Because the recombinant proteins were synthesized in the bacterial cytosol, we first tested the redox state of their cysteine residues. To this end, purified Cox19 and Cox19^EE^ were incubated with mm(PEG)~12~ ([Figure 6A](#F6){ref-type="fig"}). Both proteins were not modified by mm(PEG)~12~ unless pretreated with TCEP, indicating that in Cox19 and Cox19^EE^, both disulfide bonds are formed upon expression in bacteria. Thus the introduced negative charges do not prevent cysteine oxidation per se but rather the recognition by Mia40 in the IMS.

![Cox19, but not Cox19^EE^, has potential binding affinity to three distinct regions in the IMS domain of Cox11. (A) Cox19-His~6~ and Cox19^EE^-His~6~ were recombinantly expressed in *E. coli* and purified. The protein was denatured and treated with TCEP and/or mm(PEG)~12~ and analyzed by nonreducing SDS--PAGE. Only after TCEP treatment are the cysteine residues in Cox19-His~6~ and Cox19^EE^-His~6~ accessible to alkylation, indicating that the recombinant protein is fully oxidized. (B, C) Peptides 20 residues in length corresponding to the IMS domain of Cox11 were spotted onto a nylon membrane and incubated with Cox19-His~6~ or Cox19^EE^-His~6~, respectively, as indicated. After extensive washing, bound protein was transferred to nitrocellulose and analyzed by immunoblotting with monoclonal antihexahistidine antibodies. The signals were quantified. The regions specifically bound to Cox19-His~6~, but none of the peptides was bound by Cox19^EE^-His~6~, although the protein was efficiently recognized by the antihexahistidine antibody (D). (E) The structure of yeast Cox11 was modeled on the basis of the Cox11 structure (PDB 1SP0) of *S. meliloti* ([@B4]). The three binding regions are shown in red.](2385fig6){#F6}

Next we spotted two identical nylon membranes with 65 peptides of 20 amino acid residues in length, each representing the entire sequence of the IMS domain of Cox11 (residues 108--300). The peptides represented residues 91--110, 94--113, 97--116,..., 280--299, and 281--300. We incubated these membranes with recombinantly expressed purified Cox19-His~6~ and Cox19^EE^-His~6~, respectively ([Figure 6, B and C](#F6){ref-type="fig"}). The membranes were washed, and Cox19/Cox19^EE^ bound to the peptides was transferred to nitrocellulose and detected by immunoblotting with a monoclonal hexahistidine antibody that recognized the Cox19-His~6~ and the Cox19^EE^-His~6~ protein equally well ([Figure 6D](#F6){ref-type="fig"}). Strong Cox19 signals were detected at three regions of Cox11, whereas Cox19^EE^ did not bind to any of the peptides. This result again confirmed that Cox11 binding by Cox19 depends on the conserved YL residues of the Cx~9~C region. Chou--Fasman algorithms predict helical structures for all Cox11 peptides bound by Cox19 ([@B18]). However, when we modeled the yeast Cox11 structure onto the published Cox11 structure of *Sinorhizobium meliloti* ([@B4]; [Figure 6E](#F6){ref-type="fig"}), region 1 was directly N-terminal to the crystallized Cox11 fragment and contained a strictly conserved cysteine residue of Cox11. This cysteine is not part of the copper-binding site but is essential for cytochrome *c* oxidase biogenesis, although its specific function is unclear ([@B4]; [@B14]; [@B73]).

Cox19 binds to Cox11 in a redox-sensitive manner
------------------------------------------------

To better characterize the conditions under which Cox19 binds to Cox11, we developed an in vitro binding assay using immobilized recombinant Cox19-His~6~ (or Cox19^EE^-His~6~ for control) and mitochondrial extracts ([Figure 7A](#F7){ref-type="fig"}). To this end, Cox19-His~6~ or Cox19^EE^-His~6~ was immobilized on Ni-NTA Sepharose beads and incubated with Triton X-100--lysed mitochondria. Subsequently, proteins in the nonbound (NB) and bound (E, eluate) fractions were analyzed by Western blotting ([Figure 7B](#F7){ref-type="fig"}). We found that Cox11 was efficiently bound by Cox19-His~6~ on the resin, whereas Cox11 was not recovered with Cox19^EE^-His~6~ or with noncoated Sepharose beads. The interaction between Cox11 and Cox19 was not significantly influenced by the addition of copper sulfate or the copper chelator bathocuproine disulfonate (BCS), indicating that copper is not critical for the Cox11--Cox19 interaction. In contrast, the binding of Cox11 to Cox19-His~6~ was fully prevented in the presence of 5 mM reduced glutathione (GSH; [Figure 7C](#F7){ref-type="fig"}). To test whether this GSH sensitivity is an effect of the reductant on Cox11 or on Cox19, we exclusively preincubated the mitochondria with GSH. Then we removed the reductant by extensive washing before the mitochondria were lysed. This pretreatment compromised the binding of Cox11 to the immobilized Cox19-His~6~, indicating that GSH treatment converts Cox11 into a species that does not efficiently interact with Cox19 ([Figure 7D](#F7){ref-type="fig"}).

![Cox11 binds to Cox19 in a glutathione-dependent manner. (A, B) Purified Cox19-His~6~ or Cox19^EE^-His~6~ was immobilized on Sepharose beads and incubated with extracts of mitochondria expressing Cox11-HA. After washing, proteins of the total (T), not-bound (NB), and bound (E, eluate) fractions were analyzed by Western blotting. Cox11 was detected by use of an HA antibody. For the mock sample, naive Sepharose beads were used that carried neither Cox19-His~6~ nor Cox19^EE^-His~6~. In the samples labeled with BCS and CuSO~4~, 4 mM bathocuproine disulfonate or 100 μM copper sulfate, respectively, was added to 450 μg of wild-type mitochondria. After 15 min of incubation, the mitochondria were recovered by centrifugation and lysed. The clarified lysate was incubated with Cox19-coated Sepharose beads. (C,E) Pull-down experiments with naive beads (mock) or immobilized Cox19-His~6~ (other samples) as described in B, with the exception that different amounts of reduced glutathione (GSH) or oxidized glutathione disulfide (GSSG) were present during the binding reaction. (D) Mitochondria were preincubated with 5 mM reduced glutathione. The glutathione was removed by washing. Mitochondria were lysed, and the resulting extract was used for binding experiments as described in B. (F--H) Mitochondria expressing Cox19 with a hexahistidine tag were pretreated in the absence or presence of 5 mM GSH or GSSG for 15 min at 30°C. The mitochondria were washed and lysed in a buffer containing 1% Triton X-100, and the extract was clarified by centrifugation. Cox19-His~6~ was precipitated by 1 h incubation with Ni-NTA Sepharose and, after several washing steps, eluted with 250 mM imidazole. The T and NB samples correspond to 1% of the material used for the E sample. The samples were analyzed by Western blotting, and the signal intensities were quantified.](2385fig7){#F7}

On the contrary, in the presence of oxidized glutathione disulfide (GSSG), the association of Cox11 and Cox19 was strongly increased, suggesting that oxidized glutathione converts Cox11 into a species that is competent for Cox19 binding ([Figure 7E](#F7){ref-type="fig"}). This suggests that the redox states of the cysteines in Cox11 determine its affinity for Cox19.

Next we tested whether GSH and GSSG also influence the Cox11--Cox19 association in mitochondria ([Figure 7F](#F7){ref-type="fig"}). To this end, we preincubated mitochondria in the absence or presence of 5 mM GSH or GSSG for 15 min at 30°C. After extensive washing to remove glutathione, we lysed the mitochondria and used the extracts for coimmunoprecipitation with Cox19 antibodies ([Figure 7G](#F7){ref-type="fig"}). The amount of Cox19, as well as of coisolated Cox11 and Mia40 for control, was detected by Western blotting and quantified ([Figure 7H](#F7){ref-type="fig"}). Consistent with the in vitro experiments, reduced GSH impaired the Cox19--Cox11 interaction, whereas preincubation with GSSG strongly increased the levels of Cox11 that were recovered with Cox19. This suggests that an oxidative modification of Cox11 increases its affinity for Cox19.

Cox11 contains a disulfide between C^208^ and C^210^ that depends on C^111^
---------------------------------------------------------------------------

The strong influence of glutathione on the Cox11--Cox19 interaction inspired us to test whether the redox state of the three cysteine residues in Cox11 is altered in *Δcox19* mutants. To this end, we precipitated mitochondrial proteins with trichloroacetic acid (TCA), since low pH prevents cysteine oxidation. Then we denatured the proteins and incubated them with mm(PEG)~24~ to assess the accessibility of cysteine residues ([Figure 8A](#F8){ref-type="fig"}). In wild-type mitochondria, Cox11 was efficiently shifted up after pretreatment with the reductant TCEP due to the addition of presumably three mm(PEG)~24~ groups to the three cysteine residues of Cox11 ([Figure 8A](#F8){ref-type="fig"}, lane 2). Treatment with BCS or copper sulfate did not considerably influence the accessibility of the cysteine residues to mm(PEG)~24~ ([Figure 8A](#F8){ref-type="fig"}, lanes 3 and 4). In contrast, when extracts of *Δcox19* mitochondria were analyzed, two different species were observed after treatment with mm(PEG)~24~, one that resembled the fully reduced species, which was also observed in wild-type mitochondria, and a second form in which only two mm(PEG)~24~ moieties were bound to Cox11 ([Figure 8A](#F8){ref-type="fig"}, lanes 6--8). This indicates that a Cox11 species accumulates in *Δcox19* mitochondria in which one cysteine residue does not react with the maleimide group of the mm(PEG)~24~, even after treatment with the strong reductant TCEP. This suggests that here one cysteine is overoxidized to the sulfinic or sulfonic acid state. The incomplete alkylation observed in *Δcox19* mitochondria is not the consequence of the absence of cytochrome *c* oxidase in this mutant, as the variant in which three mm(PEG)~24~ moieties are bound to Cox11 was the predominant form in *Δcox6* mitochondria ([Figure 8A](#F8){ref-type="fig"}, lanes 10--12). Hence we conclude that Cox19 is critical to maintain the cysteine residues in Cox11 in a functional state.

![In Cox11, C^208^--C^210^ are partially oxidized in a C^111^-dependent manner. (A) Proteins of wild-type or *Δcox19* mitochondria were TCA precipitated to prevent cysteine oxidation, denatured in SDS, and incubated with TCEP and mm(PEG)~24~ as indicated. Mitochondria were pretreated with or without 2 mM BCS or 100 μM copper sulfate for 10 min at 30°C before TCA precipitation. Samples were analyzed by Western blotting. (B) Proteins of wild-type mitochondria were TCA precipitated and incubated as indicated with or without TCEP, 5 mM diamide, 5 mM reduced (GSH) or oxidized (GSSG) glutathione, or first with 100 μM copper sulfate for 15 min before copper was again removed by addition of 2 mM BCS. Then free thiols were alkylated with mm(PEG)~24~. (C) The redox state of Cox11 in wild-type and *Δcox19* mitochondria was determined as described in B. (D) Growth test for the indicated strains. (E) Protein levels in isolated mitochondria of the indicated strains as determined by Western blotting. (F, G) The redox state of Cox11 in mitochondria of the indicated mutants was determined as described in B. When indicated, mitochondria were pretreated with BCS to remove copper ions. Yellow arrowheads indicate steady-state redox conditions, and purple arrows point at samples in which disulfide bond formation was induced by oxidants. (H) Model for the Cox19--Cox11 interaction. Cox11 contains three cysteine residues. The regions in Cox11 that show affinity to Cox19 include the conserved cysteine C^111^ right after the transmembrane domain (shown here as a black box). Cox19 binding promotes disulfide bond formation in the copper-binding site of Cox11, potentially by preventing overoxidation of C^111^ (red asterisk).](2385fig8){#F8}

Next we assessed the redox state of Cox11 in wild-type mitochondria. We again tested the accessibility to mm(PEG)~24~ but omitted the pretreatment with TCEP to monitor the endogenous redox state ([Figure 8B](#F8){ref-type="fig"}). Surprisingly, we observed that in the prevalent fraction of Cox11, only one cysteine was accessible and two were blocked, suggesting that Cox11 contains a disulfide bond. Preincubation with oxidants such as diamide or copper sulfate shifted the entire Cox11 fraction into that form. Oxidized Cox11, albeit in lower amounts, were still found after pretreatment of mitochondria with physiological concentrations of glutathione ([Figure 8B](#F8){ref-type="fig"}, GSH). The disulfide bond is presumably formed in the surface-exposed C^208^xC^210^ motif, which is part of the copper-binding site ([@B4]; [@B73]). Of interest, in mitochondria isolated from *Δcox19* cells, a considerably smaller fraction of Cox11 contained the disulfide bond, suggesting that Cox19 maintains Cox11 in an oxidation-competent form ([Figure 8C](#F8){ref-type="fig"}).

Next we tested whether the cysteine in position 111 affects the redox state of C^208^ and C^210^ in Cox11. First we replaced the C^111^ residue by alanine or aspartate, the latter mimicking the negative charge of sulfenylated or glutathionylated cysteines. Both mutations completely compromised Cox11 activity, resulting in respiration-deficient mutants ([Figure 8D](#F8){ref-type="fig"}) that do not contain detectable levels of cytochrome *c* oxidase ([Figure 8E](#F8){ref-type="fig"}). When we assessed the thiol redox state in these Cox11 mutants, we found that C^208^ and C^210^ were accessible to mm(PEG)~24~ unless chemical oxidants such as copper sulfate ([Figure 8F](#F8){ref-type="fig"}) or diamide ([Figure 8G](#F8){ref-type="fig"}) were added. From this, we conclude that disulfide bond formation between C^208^ and C^210^ depends on the presence of the conserved cysteine residue at position 111, which is part of the presumed Cox19 binding site ([Figure 8H](#F8){ref-type="fig"}).

DISCUSSION
==========

Proteins of the mitochondrial IMS play important roles in transport of molecules between mitochondria and the cytosol, biogenesis of the respiratory chain, and redox homeostasis ([@B35]). Despite their relevance, surprisingly little is known about the biogenesis and function of most of these proteins. The iAAA protease Yme1 is the only characterized ATP-hydrolyzing enzyme of the IMS ([@B51]; [@B66]), and it is largely unclear how protein functions in this compartment are controlled. During evolution, the IMS was derived from the bacterial periplasm, which lacks ATP and, hence, ATP-hydrolyzing enzymes ([@B55]; [@B31]). The ATP-independent strategies to regulate protein activities in the periplasm might therefore also be used by eukaryotic cells to control protein functions in the IMS of mitochondria.

Twin Cx~9~C proteins constitute the largest group of IMS proteins: in yeast, 14 of the 31 soluble IMS proteins, and in humans, 29 of the 127 IMS proteins, belong to this family ([@B29]; [@B52]; [@B15]; [@B79]; [@B38]). Although they are numerous, evolutionarily conserved, and of similar overall structure, we know almost nothing about their molecular functions. We therefore used an unbiased quantitative proteomic approach to identify interactors of the conserved twin Cx~9~C protein Cox19 that may shed light on the molecular function of this conserved IMS protein.

Cox19 has a helix-turn-helix structure with a hydrophobic surface on one side that is characterized by two adjacent leucine-tyrosine residues. As reported here, these residues are essential for Cox19 function and critical for its ability to bind to the IMS domain of Cox11. We identified three regions in Cox11 that showed affinity for Cox19. All Cox19-binding peptides are predicted to form α-helical structures with one hydrophobic surface and contain the aromatic residues phenylalanine or tyrosine. However, the published bacterial Cox11 structure suggests that in the context of the folded protein, region 2 is part of a β-sheet. Peptides of regions 2 and 3 lack cysteine residues, but the helical nature and the hydrophobic residues are similar to, although still distinct from, the MISS/ITS signals that are recognized by the hydrophobic substrate-binding region of Mia40 ([@B57]; [@B67]). Cox19 apparently has a similar protein-binding activity as Mia40; however, in the case of Cox19, this activity is not required for the import of its binding partner Cox11 but rather for Cox11 function.

The precise role of Cox11 during biogenesis of cytochrome *c* oxidase is not clear, despite some considerable interest in the protein since several genome-wide association studies recently reported that a single-nucleotide polymorphism in the human Cox11 gene is an important risk factor for breast cancer ([@B1]; [@B25]). Cox11 was shown to be required for the incorporation of the Cu(B) center into Cox1. Cox11 can accept copper from the copper-binding protein Cox17 ([@B37]), suggesting that it serves as a shuttle mediating copper transfer from Cox17 to Cox1. Similar copper transfer factors are known for the Cu(A) site of cytochrome *c* oxidase and the copper/zinc superoxide dismutase (Sod1), for which metalation is mediated by Sco1 and Ccs1, respectively ([@B64]; [@B48]; [@B6]; [@B32]).

The IMS domain of Cox11, which exhibits the main activity of the protein, contains three conserved cysteine residues, all of which are essential for its function ([@B7]). The surface-exposed C^208^xC^210^ motif in Cox11 (compare [Figure 6E](#F6){ref-type="fig"}) presumably constitutes the copper-binding site. The function of cysteine C^111^, which is located directly C-terminal of the transmembrane region, is not clear, but it was suggested that C^111^ is involved in the metalation of Cox1 ([@B73]). It was also speculated that C^111^ mediates homodimerization of Cox11 by the formation of an intermolecular disulfide ([@B4]), but at least in the bacterium *Rhodobacter sphaeroides*, no evidence for homodimers was found ([@B73]). Similarly, we did not observe Cox11 dimers under different conditions tested (unpublished results). The alkylation experiments in this study suggest that Cox11 can form an intramolecular disulfide between C^208^ and C^210^ that is less efficiently formed in *Δcox19* mitochondria and absent if C^111^ is mutated. In addition, we observe a TCEP-resistant modification of presumably C^111^ in *Δcox19* mitochondria, suggesting that Cox19 protects C^111^ of Cox11 against overoxidation to a sulfenic, sulfinic, or sulfonic acid form ([Figure 8H](#F8){ref-type="fig"}).

Hence the absence of Cox19 might block the reaction cycle of Cox11 at a stage that makes the protein particularly redox sensitive and therefore leads to overoxidation and inactivation of Cox11.

Our Cox11--Cox19 in vitro binding assay showed that pretreatment of Cox11 with glutathione disulfide strongly stimulated its binding by Cox19, and, on the contrary, reduced glutathione basically abolished the Cox19--Cox11 interaction. Hence the redox state of the cysteine residues in Cox11 obviously determines its interaction with Cox19 ([Figure 7G](#F7){ref-type="fig"}). It is unclear whether the observed cysteine oxidation step is directly linked to the copper transfer, but the observation that addition or removal of copper did not affect the Cox19--Cox11 interaction suggests that the binding of Cox19 to Cox11 is not triggered by copper binding. Of interest, it was recently shown that in human cells, Cox19 can be released from the IMS to regulate copper efflux from the Golgi-localized, ATP7A copper-transporting ATPase ([@B49]). Cox19 release thereby correlates with the redox state of cysteine residues in Sco1 and Sco2, the copper chaperones for the Cu(A) site of cytochrome *c* oxidase. A direct interaction of Cox19 with Sco1 or Sco2 was not reported in that study, nor did we find Sco1 or Sco2 in our Cox19 interactome. It is conceivable that perturbation of Sco1 function impairs the Cox11--Cox19 interaction and thereby allows Cox19 to be exported back from the IMS to the cytosol.

The interaction of Cox19 with Cox11 in the IMS is reminiscent of the recently observed interaction of the twin Cx~9~C protein Mdm35 with the lipid-binding protein Ups1 ([@B63]; [@B72]). Ups1 binds phosphatidic acid at the IMS side of the mitochondrial outer membrane and transfers it to the inner membrane ([@B19]). In this process, Mdm35 is critical to maintaining Ups1 in a transfer-competent state, although its precise role in this reaction is not entirely clear. The overall structure of Mdm35 is similar to that of Cox19, and it even has the same conserved tyrosine residues at the same positions (twin Cx~6~Yx~2~C). Hence the principles by which Mdm35 supports Ups1-mediated lipid transfer might be similar to those by which Cox19 mediates Cox11-mediated copper transfer in the IMS. Possibly, twin Cx~9~C proteins might play a general function as folding modulators in the IMS that drive reactions in this compartment by a dynamic interaction with their client proteins. Thereby the function of IMS proteins might be controlled in an ATP-independent manner by modulations of conformational states triggered by the association or dissociation of twin Cx~9~C proteins. It will be exciting to develop an in vitro assay in which the Cox11-mediated copper transfer from Cox19 to Cox1 can be studied to dissect the precise functions of Cox19 in facilitating the redox-dependent copper transfer by Cox11.

MATERIALS AND METHODS
=====================

Yeast strains and media
-----------------------

The strains used for SILAC analysis were derived from YPH499 *Δarg4* ([@B78]). To generate YPH499 *Δarg4* Cox19-His~6~, the *Schizosaccharomyces pombe HIS5* cassette from pFA6a-His3MX6 was amplified with primers with homologous ends to the 3′ untranslated region replacing the stop codon of *COX19*. The forward primer contained the sequence for six histidine residues followed by a stop codon. The resulting product was transformed into YPH499 *Δarg4* and integrated into the DNA by homologous recombination.

All other yeast strains were derived from the wild-type strain W303 ([@B84]). His~6~ tagging of Cox11 and Cox19 was done as described. For addition of a 3× hemagglutinin (3xHA) tag to Cox11, a genomic integration strategy was used employing the *Kluyveromyces lactis TRP1* cassette with a 3xHA tag from a pYM22 vector ([@B39]).

For deletion of *COX19*, the open reading frame was replaced by homologous recombination with the *spHIS5* cassette from pFA6a-His3MX6 ([@B12]). The *Δcox11* strain was made by replacing the *COX11* reading frame by a KanMX4 cassette. For deletion of *YME1*, the open reading frame was replaced by *URA3* from *Saccharomyces cerevisiae*.

Cox11 and Cox19 overexpression plasmids were made by amplifying the coding regions of the genes with additional 300 base pairs upstream and 150 base pairs downstream and inserting them via *Hin*dIII and *Bam*HI into pRS426 ([@B68]). The pRS426 plasmid containing *COX19* was used for QuikChange Site-Directed Mutagenesis (Stratagene, Santa Clara, CA) to generate in the first step the mutations Y37E and L38E and in the second step Y59E and L60E. For generation of IM-Cox19 and IM-Cox19^EE^, the coding sequences of Cox19 and Cox19^EE^ were amplified from the respective pRS426 plasmids and inserted using *Bam*HI and *Xho*I into pYX223 (Novagen, Darmstadt, Germany), which contained the sequence for the first 75 amino acids of Mia40 between the *Eco*RI and *Bam*HI sites.

pGEM plasmids (Promega, Fitchburg, WI) were used to synthesize radiolabeled Cox11 and Cox19. *COX11* was inserted into pGEM3 via *Hin*dIII and *Bam*HI. pGEM4-Cox19 was previously described ([@B8]).

Yeast strains were grown in YP (1% yeast extract and 2% peptone) or minimal medium with 2% glucose or galactose as carbon sources at 30°C ([@B3]). For the SILAC labeling, the carbon source of the medium was glycerol. The wild type (YPH499 Δ*arg4*) was grown in medium containing \[^13^C~6~/^15^N~4~\][l]{.smallcaps}-arginine and \[^13^C~6~/^15^N~2~\][l]{.smallcaps}-lysine, and the strain expressing Cox19-His~6~ was grown in medium with \[^12^C/^14^N\]arginine and lysine ([@B78]).

Purification of recombinant Cox19
---------------------------------

The coding sequence without the stop codon of Cox19 and Cox19^EE^ was amplified from pRS426-Cox19 or Cox19^EE^ and cloned into pET22b (Novagen) upstream of a hexahistidine sequence using the restriction sites *Bam*HI and *Xho*I. These plasmids were transformed into *E. coli* Rosetta 2(DE3) cells (Merck, Billerica, MA). The cells were grown at 37°C to an OD~600~ of 0.6 before expression was induced by the addition of 1 mM isopropyl-β-[d]{.smallcaps}-thiogalactoside (IPTG) for 4 h at 37°C. The native purification of the recombinant proteins was performed as described in protocols 9 and 12 of the QIAexpressionist Handbook (Qiagen, Venlo, Netherlands).

Generation of antibodies against Cox11 and Cox19
------------------------------------------------

The sequence corresponding to the IMS domain of Cox11 (bases 301--903) was cloned downstream of the sequence for a hexahistidine tag of the pET16b plasmid (Novagen) using the restriction sites *Nde*1 and *Bam*H1. The plasmid was transformed into *E. coli* BL21-(DE3) cells (Novagen), and positive cells were grown at 37°C in LB~Amp~ (1% tryptone, 0.5% yeast extract, 0.5% NaCl, 100 mg/l ampicillin) to an OD~600~ of 0.6. Subsequently, gene expression was induced by the addition of 0.5 mM IPTG. After 4 h of induction at 37°C cells, were centrifuged. Cells were lysed for 10 min with vortexing and subsequent sonication in a buffer containing 8 M urea, 10 mM Tris, and 100 mM NaH~2~PO~4~, pH 8.0. Cell debris was removed by centrifugation, and Ni-NTA resin (Qiagen) was added to the supernatant. This was incubated for 1.5 h at room temperature under constant agitation. After washing the column twice with 8 M urea, 10 mM Tris, and 100 mM NaH~2~PO~4~, pH 6.3, and twice with 20 mM Tris, pH 7.4, we eluted recombinant His~6~-Cox11 with 20 mM Tris, 0.1% Triton X-100, and 250 mM imidazole, pH 7.4.

Ni-NTA affinity purification
----------------------------

A 10-mg amount of isolated mitochondria was lysed in 25 mM Tris, 250 mM NaCl, 20 mM imidazole, 1% Triton X-100, and 1 mM phenylmethylsulfonyl fluoride (PMSF), pH 7.4. After a clarifying spin, 1% of the supernatant was taken as total fraction. Ni-NTA resin (Qiagen) was equilibrated in lysis buffer and added to the samples, which were subsequently incubated for 1 h at 4°C with constant tumbling. The resin was centrifuged down, and 1% of the supernatant was taken as the not-bound fraction. After three washing steps with lysis buffer without Triton X-100 and PMSF, the proteins were eluted by 10-min incubation at 4°C with of 25 mM Tris, 250 mM NaCl, and 250 mM imidazole, pH 7.4. The complete supernatants of the elution and the third washing steps were TCA precipitated and used for SDS--PAGE.

Mass spectrometry
-----------------

Protein pellets were digested and desalted as described ([@B70]). Peptides were resuspended in 12 μl of loading buffer (2% acetonitrile, 0.4% acetic acid), and 3-μl samples were analyzed in triplicate using a nanoAQUITY UPLC (Waters, Milford, MA) coupled to an LTQ-Orbitrap XL (Thermo, Waltham, MA) running in data-dependent acquisition mode as described ([@B58]), with the following modifications: resolution for MS1 scans was set to 60,000, the seven most intense precursor ions from the MS1 scan were selected for MS2 analysis, and each precursor was selected twice for MS2 analysis before it was put on a dynamic exclusion list for 30 s. The HPLC gradient ramped from 2 to 35% acetonitrile within 90 min, then to 80% acetonitrile within 5 min, followed by a 10-min wash with 80% acetonitrile and 17-min reequilibration with 2% acetonitrile.

Peptide and protein identification and quantitation were done using MaxQuant software, version 1.2.0.18 ([@B20]; [@B21]), and *Saccharomyces* Genome Database ([www.yeastgenome.org;](http://www.yeastgenome.org;) yeast orf trans all, 03-Feb-2011). For heavy labels, Arg-10 and Lys-8 was chosen, up to three tryptic miscleavages were allowed, and protein N-terminal acetylation and Met oxidation were specified as variable modifications and Cys carbamidomethylation as fixed modification. The false discovery rate was set at 1% for peptides, proteins, and sites, and minimal peptide length was seven amino acids.

Size exclusion chromatography
-----------------------------

A 3-mg amount of isolated mitochondria was lysed in 500 μl of 25 mM Tris, 250 mM NaCl, 1% Triton-X 100, and 2 mM PMSF, pH 7.4. After a purifying centrifugation at 25,000 × *g* for 30 min at 4°C, the clarified extract was applied to a HiLoad 16/60 Superdex 200 column (GE Healthcare, Chalfont St Giles, United Kingdom) and separated with 25 mM Tris, 250 mM NaCl, and 0.1% Triton-X 100, pH 7.4. Proteins were precipitated from the collected 1-ml fractions by addition of TCA and analyzed by Western blotting.

Protein import into mitochondria
--------------------------------

Radiolabeled Cox11 and Cox19 were synthesized in vitro using the TNT T7 Quick Coupled Transcription/Translation Kit (Promega) from the plasmids pGEM3-Cox11 and pGEM4-Cox19. To avoid premature protein oxidation, protein synthesis of Cox19 was performed under hypoxic conditions. The import reactions and their analyses were performed as described previously ([@B56]). The import reaction for Cox19 also contained 5 mM GSH. To remove nonimported protein, mitochondria were treated with 100 μg/ml proteinase K for 30 min on ice after the import reactions.

COX activity assay
------------------

The assay was performed as previously described ([@B71]).

Immunoprecipitation
-------------------

A 1-mg amount of mitochondria was lysed in 100 mM NaH~2~PO~4~, 100 mM NaCl, 0.1% Triton X-100, and 2 mM PMSF, pH 8.0. After a clarifying spin, 5% of the supernatant was taken as total fraction. In lysis buffer, equilibrated protein A--Sepharose beads (Expedeon, Harston, United Kingdom) were added, to which antibodies against Cox11 were bound. The samples were incubated for 1 h at 4°C with constant tumbling. The beads were centrifuged down, and 5% of the supernatant was taken as the not-bound fraction. After two washing steps with lysis buffer and one with lysis buffer without Triton X-100 and PMSF, the proteins were eluted by 5-min incubation at 96°C with Laemmli buffer. The complete supernatant was used as the elution fraction.

Determination of the redox state of Cox11 and Cox19
---------------------------------------------------

For Cox11, 200 μg of isolated mitochondria was added to 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.4, with 2 mM BCS, 100 μM CuSO~4~, or no additional chemicals. After 10 min of incubation at 30°C, the samples were precipitated by addition of 12% TCA and incubated overnight at −20°C. The samples were centrifuged for 15 min at 4°C and 20,000 × *g* and washed with ice-cold acetone; the resulting pellet was dried and then resolved in modification buffer (80 mM Tris, pH 7 (HCl), 10% glycerol, 2% SDS, bromocresol purple). For Cox19, 12.5 μg of the isolated protein was directly added to the modification buffer. mm(PEG)~24~ (Thermo Scientific) was used for the alkylation of Cox11, and mm(PEG)~12~ was used for Cox19. To alkylate all cysteine residues in the proteins ("maximum shift"), samples were pretreated at 96°C with modification buffer containing 20 mM of thiol-free reductant TCEP before 15 mM methyl-PEG~12/24~-maleimide was added. As unmodified control ("minimum shift"), one sample was mock treated with modification buffer without mm(PEG)~12/24~. After addition of mm(PEG)~12/24~, all samples were incubated for 1 h in darkness.

Peptide scan
------------

Twenty-six peptides of 20 residues each shifted by three amino acids to cover the sequence of the IMS domain of Cox11 were spotted two times onto cellulose membranes ([@B28]; [@B46]). The membranes were incubated at room temperature for 2 min in methanol, washed for 2 min with H~2~O, and equilibrated for 20 min with binding buffer (20 mM Tris-HCl, pH 7.0, 20 mM NaCl). Then one membrane was incubated with binding buffer containing 12.5 μM purified His~6~-tagged Cox19 and the other with Cox19^EE^. After washing twice for 10 min with binding buffer and twice for 10 min with 10 mM Tris-HCl, pH 7.4, and 150 mM NaCl, the bound Cox19 was transferred onto a nitrocellulose membrane used for Western blotting with hexahistidine-specific antibodies ([@B82]).

In vitro binding assay with recombinant Cox19
---------------------------------------------

A 450-μg amount of isolated mitochondria was lysed in 500 μl lysis buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 10 mM imidazole, 0.1% Triton X-100, 1 mM PMSF, pH 8.0) during incubation at 4°C for 10 min. After a clarifying spin at 20,000 × *g* for 10 min, 5% of the supernatant was taken as the total fraction. The rest was added to 20 μl Ni-NTA agarose beads (Qiagen) that were equilibrated with binding buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 20 mM imidazole, pH 8.0). A 10-μg amount of recombinant His~6~-tagged Cox19 or Cox19^EE^ was added. The samples were incubated for 1 h at 4°C with constant agitation. The beads were centrifuged down, and 5% of the supernatant was taken as the not-bound fraction. The beads were washed four times with binding buffer before they were incubated for 5 min at 30°C with 25 μl of elution buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 250 mM imidazole, pH 8.0). The beads were centrifuged down, and the supernatant was taken as the elution fraction.
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BCS

:   bathocuproine disulfonate

GSH

:   glutathione

GSSG

:   glutathione disulfide

IM

:   inner membrane

IMS

:   intermembrane space

ITS

:   IMS-targeting signal

MISS

:   mitochondrial IMS-sorting signal

mm(PEG)

:   methyl-polyethylene glycol maleimide

SILAC

:   stable isotope labeling by amino acids in cell culture

TCA

:   trichloroacetic acid

TCEP

:   Tris-carboxyethyl phosphine.
